Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of VSTM5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 86% | 37.89 | 283 / 328 | 72% | 2.21 | 128 / 178 |
intestine | 99% | 145.97 | 959 / 966 | 58% | 2.18 | 305 / 527 |
stomach | 92% | 113.54 | 332 / 359 | 54% | 1.46 | 155 / 286 |
brain | 95% | 253.43 | 2502 / 2642 | 43% | 1.07 | 305 / 705 |
prostate | 97% | 81.75 | 238 / 245 | 39% | 0.85 | 198 / 502 |
bladder | 86% | 36.76 | 18 / 21 | 33% | 0.94 | 165 / 504 |
kidney | 91% | 79.45 | 81 / 89 | 26% | 0.49 | 236 / 901 |
uterus | 90% | 63.68 | 153 / 170 | 27% | 0.70 | 122 / 459 |
esophagus | 60% | 25.22 | 871 / 1445 | 56% | 2.11 | 103 / 183 |
breast | 80% | 44.43 | 365 / 459 | 21% | 0.96 | 234 / 1118 |
adrenal gland | 38% | 12.04 | 99 / 258 | 35% | 0.88 | 81 / 230 |
thymus | 63% | 23.69 | 410 / 653 | 4% | 0.06 | 23 / 605 |
adipose | 64% | 30.21 | 766 / 1204 | 0% | 0 | 0 / 0 |
lung | 22% | 6.54 | 126 / 578 | 39% | 1.12 | 456 / 1155 |
skin | 57% | 21.97 | 1030 / 1809 | 4% | 0.08 | 18 / 472 |
ovary | 38% | 15.78 | 69 / 180 | 12% | 0.24 | 51 / 430 |
blood vessel | 47% | 16.23 | 632 / 1335 | 0% | 0 | 0 / 0 |
heart | 38% | 12.19 | 327 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 1.35 | 8 / 45 |
muscle | 7% | 1.82 | 56 / 803 | 0% | 0 | 0 / 0 |
liver | 2% | 0.44 | 5 / 226 | 4% | 0.10 | 16 / 406 |
spleen | 0% | 0.09 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.03 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046847 | Biological process | filopodium assembly |
GO_0051260 | Biological process | protein homooligomerization |
GO_1904891 | Biological process | positive regulation of excitatory synapse assembly |
GO_0021517 | Biological process | ventral spinal cord development |
GO_0030424 | Cellular component | axon |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030425 | Cellular component | dendrite |
Gene name | VSTM5 |
Protein name | V-set and transmembrane domain-containing protein 5 V-set and transmembrane domain containing 5 |
Synonyms | C11orf90 |
Description | FUNCTION: Cell adhesion-like membrane protein of the central nervous system (CNS) which modulates both the position and complexity of central neurons by altering their membrane morphology and dynamics. Involved in the formation of neuronal dendrites and protrusions including dendritic filopodia. In synaptogenesis, regulates synapse formation by altering dendritic spine morphology and actin distribution. Promotes formation of unstable neuronal spines such as thin and branched types. Regulates neuronal morphogenesis and migration during cortical development in the brain. . |
Accessions | ENST00000409977.2 A8MXK1 H0Y3Q1 ENST00000398221.3 |